A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes

Abstract : Background: Radiotherapy for head and neck squamous cell carcinomas (HNSCC) is associated with a substantial morbidity and inconsistent efficacy. Human papillomavirus (HPV)-positive status is recognized as a marker of increased radiosensitivity. Our goal was to identify molecular markers associated with benefit to radiotherapy in patients with HPV-negative disease. Methods: Gene expression profiles from public repositories were downloaded for data mining. Training sets included 421 HPV-negative HNSCC tumors from The Cancer Genome Atlas (TCGA) and 32 HNSCC cell lines with available radiosensitivity data (GSE79368). A radioresistance (RadR) score was computed using the single sample Gene Set Enrichment Analysis tool. The validation sets included two panels of cell lines (NCI-60 and GSE21644) and HPV-negative HNSCC tumor datasets, including 44 (GSE6631), 82 (GSE39366), and 179 (GSE65858) patients, respectively. We finally performed an integrated analysis of the RadR score with known recurrent genomic alterations in HNSCC, patterns of protein expression, biological hallmarks, and patterns of drug sensitivity using TCGA and the E-MTAB-3610 dataset (659 pancancer cell lines, 140 drugs).
Type de document :
Article dans une revue
BMC Medicine, BioMed Central, 2017, 15 (1), pp.703 - 719. 〈10.1186/s12916-017-0929-y〉
Liste complète des métadonnées

Littérature citée [52 références]  Voir  Masquer  Télécharger

https://hal.inria.fr/hal-01599731
Contributeur : Marie-France Sagot <>
Soumis le : lundi 2 octobre 2017 - 14:38:28
Dernière modification le : mardi 16 janvier 2018 - 15:34:43

Fichier

foy2017.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Jean-Philippe Foy, Louis Bazire, Sandra Ortiz-Cuaran, Sophie Deneuve, Janice Kielbassa, et al.. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes. BMC Medicine, BioMed Central, 2017, 15 (1), pp.703 - 719. 〈10.1186/s12916-017-0929-y〉. 〈hal-01599731〉

Partager

Métriques

Consultations de la notice

162

Téléchargements de fichiers

13